As of April 2024 Veracyte has a market cap of $1.46 Billion. This makes Veracyte the world's 4607th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.46 B | -27.34% |
2023 | $2.00 B | 18.01% |
2022 | $1.70 B | -41.83% |
2021 | $2.92 B | 3.3% |
2020 | $2.83 B | 104.5% |
2019 | $1.38 B | 169.53% |
2018 | $0.51 B | 131.27% |
2017 | $0.22 B | 2.75% |
2016 | $0.21 B | 8.53% |
2015 | $0.19 B | -8.38% |
2014 | $0.21 B | -29.03% |
2013 | $0.30 B |
On Apr 25th, 2024 the market cap of Veracyte was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Exact Sciences EXAS | $10.67 B | 631.31% | ๐บ๐ธ USA |
Myriad Genetics MYGN | $1.64 B | 12.72% | ๐บ๐ธ USA |
Biocept
BIOC | $1.14 M | -99.92% | ๐บ๐ธ USA |